Atlas Trials

An Open-label, Dose-ascending Study of IGT001 for Retinitis Pigmentosa

Clinical trial NCT06936787 · RECRUITING

Trial details

NCT number
NCT06936787
Sponsor
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Retinitis Pigmentosa
Start date
2025-04-20
Primary completion
2025-12-20
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.